According to online reports, health technology company Semler Scientific (SMLR) has held 5,021 bitcoins as of July 31, which is approximately US$585 million based on the current market price. Its net profit of $66.9 million came entirely from bitcoin-related gains (Bitcoin unrealized gains reached $83.8 million). Benchmark analysts maintain a "buy" rating on Semler and a price target of $121, pointing out that although the company's main diagnostic business is dragged down by medical insurance policies, its "slow-money" bitcoin buying strategy has long-term potential. Joe Burnett, Semler's new director of bitcoin strategy, said that the company will gradually increase its holdings of bitcoin through cash flow, low-cost debt and limited additional issuance. The goal is to hold 10,000 bitcoins by the end of 2025, 42,000 by the end of 2026, and 105,000 at the end of 2027. In addition, Semler is expanding its SaaS business CardioVanta to achieve stable cash flow to support future Bitcoin holdings. Although its share price has fallen nearly 40% during the year, Benchmark believes current valuations do not reflect the upside potential of its Bitcoin strategy.